Literature DB >> 7436564

Tienilic acid: a single treatment for hyperuricaemia and hypertension?

T Gibson, V A Rodgers, C F Potter, H A Simmonds.   

Abstract

Tienilic acid is a drug with established uricosuric and hypotensive properties. We have examined its potential role as a single treatment for hyperuricaemia and hypertension, 2 disorders which are commonly associated. In 17 subjects with gout, blood uric acid levels were reduced by approximately 50%. Eleven of these patients also had hypertension which was improved by tienilic acid. However, a statistically significant effect was observed only with standing diastolic blood pressure. Side effects included acute episodes of gout in 4 patients and transient loin pain and dysuria in 1 patient. The precipitation of gouty arthritis is an acknowledged risk of all potent hypouricaemic drugs. The hazard of urate deposition in the renal tract implicit in the history of loin pain is a more serious complication. Thus, it would appear that tienilic acid is a potentially valuable drug which may have a special role in patients with hyperuricaemia and hypertension. Further study is necessary to determine how it may be best administered without the risk of renal damage.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7436564      PMCID: PMC1000559          DOI: 10.1136/ard.39.4.373

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  11 in total

1.  Treatment of arterial hypertension with tienilic acid, a new diuretic with uricosuric properties.

Authors:  G Lemieux; M Beauchemin; A Gougoux; P Vinay
Journal:  Can Med Assoc J       Date:  1978-05-06       Impact factor: 8.262

2.  Serum uric acid. Its relationship to coronary heart disease risk factors and cardiovascular disease, Evans County, Georgia.

Authors:  R Klein; B E Klein; J C Cornoni; J Maready; J C Cassel; H A Tyroler
Journal:  Arch Intern Med       Date:  1973-09

3.  The rapid determination of urinary titratable acid and ammonium and evaluation of freezing as a method of preservation.

Authors:  J C Chan
Journal:  Clin Biochem       Date:  1972-06       Impact factor: 3.281

4.  Clinical survey of 354 patients with gout.

Authors:  R Grahame; J T Scott
Journal:  Ann Rheum Dis       Date:  1970-09       Impact factor: 19.103

5.  Epidemiology of serum uric acid among 8000 Japanese-American men in Hawaii.

Authors:  K Yano; G Rhoads; A Kagan
Journal:  J Chronic Dis       Date:  1977-03

6.  Acute renal failure from ticrynafen.

Authors:  W M Bennett; P E Van Zee; R Hutchings
Journal:  N Engl J Med       Date:  1979-11-22       Impact factor: 91.245

7.  Effects of different diuretics on urinary calcium excretion in a general population.

Authors:  A Goulding; G F Spears; F O Simpson
Journal:  Aust N Z J Med       Date:  1978-10

8.  Hyperuricemia in primary and renal hypertension.

Authors:  P J Cannon; W B Stason; F E Demartini; S C Sommers; J H Laragh
Journal:  N Engl J Med       Date:  1966-09-01       Impact factor: 91.245

9.  Comparison of natriuretic, uricosuric, and antihypertensive properties of tienilic acid, bendrofluazide, and spironolactone.

Authors:  C J Roberts; A J Marshall; S Heaton; D W Barritt
Journal:  Br Med J       Date:  1979-01-27

10.  Biochemical and haematological changes induced by tienilic acid combined with propranolol in essential hypertension.

Authors:  R M Pearson; C J Bulpitt; C W Havard
Journal:  Lancet       Date:  1979-03-31       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.